Search results
FDA advises Covid vaccine makers to target KP.2 for fall shots
NBC NEWS· 2 days agoThe Food and Drug Administration said Thursday it had advised drugmakers to update the Covid ...
Is It Too Late to Buy Pfizer Stock?
The Motley Fool via AOL· 1 day agoTo make matters worse, the forces behind this purported decline do not imply room for recovery. As shown on the chart, Pfizer's performance during the...
Pentagon Launched Secret Anti-Vax Campaign To Discredit China During COVID Pandemic, Report Says
Forbes· 2 days agoThe Department of Defense surreptitiously operated an anti-vaccine campaign aimed at Chinese...
Is It Too Late to Buy Pfizer Stock? | The Motley Fool
The Motley Fool· 1 day agoAre Pfizer's (PFE -0.43%) best days behind it? If the stock's critics are to be believed, the answer...
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
WFMZ Eastern Pennsylvania and Western New Jersey· 1 day agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
Here's To Science! Pfizer, Moderna Look To Combo Flu/COVID Vaccines
MediaPost· 5 days agoAlbert Bourla, Pfizer’s chief executive officer, acknowledged on Monday that, because the company’s stock price was down at the time, he gave the final sign-off on running ...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 14 hours agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
FOX Business· 7 days agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 2 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
